Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

ClinicalTrials.gov ID: NCT00863707

Public ClinicalTrials.gov record NCT00863707. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 2:55 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4, Multicenter, Double-Blind, Randomized, Placebo-controlled Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is intended to assess the safety and tolerance of regadenoson in subjects with renal impairment.

Study identification

NCT ID
NCT00863707
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Astellas Pharma Inc
Industry
Enrollment
511 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2009 (Type not available)
Primary completion
Dec 2009 (Actual)
Completion
Dec 2009 (Actual)
Last update posted
May 18, 2012

2009

United States locations

U.S. sites
41
U.S. states
19
U.S. cities
39
Facility City State ZIP Site status
Not listed Anniston Alabama 36207 —
Not listed Little Rock Arkansas 72204 —
Not listed Bell Gardens California 90202 —
Not listed Fullerton California 92835 —
Not listed Garden Grove California 92845 —
Not listed Los Angeles California 90017 —
Not listed Los Angeles California 90022 —
Not listed Mission Viejo California 92691 —
Not listed Oakland California 94609 —
Not listed Roseville California 95661 —
Not listed Santa Ana California 92704 —
Not listed Newark Delaware 19713 —
Not listed Wilmington Delaware 19808 —
Not listed Fort Lauderdale Florida 33308 —
Not listed Miami Florida 33173 —
Not listed Orlando Florida 32809 —
Not listed Trinity Florida 34655 —
Not listed Winter Park Florida 32789 —
Not listed Ellijay Georgia 38540 —
Not listed Chicago Illinois 60616 —
Not listed Auburn Maine 04210 —
Not listed Detroit Michigan 48202 —
Not listed Flint Michigan 48504 —
Not listed Minneapolis Minnesota 55415 —
Not listed Ridgewood New Jersey 07450 —
Not listed Somerset New Jersey 08873 —
Not listed New York New York 10010 —
Not listed Springfield Gardens New York 11413 —
Not listed Springfield Ohio 45505 —
Not listed Oklahoma City Oklahoma 73103 —
Not listed Bend Oregon 97701 —
Not listed Duncansville Pennsylvania 16635 —
Not listed Indiana Pennsylvania 15701 —
Not listed Tyrone Pennsylvania 16686 —
Not listed Wyomissing Pennsylvania 19610 —
Not listed Charleston South Carolina 29425 —
Not listed Spartanburg South Carolina 29303 —
Not listed Knoxville Tennessee 37920 —
Not listed Houston Texas 77055 —
Not listed Houston Texas 77074 —
Not listed Sugar Grove Texas 77478 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00863707, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 18, 2012 · Synced Nov 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00863707 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →